Welcome to our dedicated page for Phinia SEC filings (Ticker: PHIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PHINIA Inc. filings document the reporting obligations of an operating industrial supplier focused on fuel systems, electrical systems and aftermarket solutions. The company’s 8-K reports furnish quarterly and annual operating results, financial condition updates and related earnings materials.
PHINIA’s regulatory record also includes proxy disclosures covering board matters, executive compensation, equity awards and shareholder voting items. Material-event filings document changes in the company’s certifying accountant, a settlement agreement, and tax matters tied to PHINIA’s July 2023 separation from BorgWarner.
PHINIA Inc. is soliciting proxies for its 2026 annual meeting, where shareholders will vote on electing eight directors, approving executive compensation on an advisory basis, and ratifying Deloitte & Touche LLP as independent auditor for 2026.
The company highlights 2025 performance including a 33% total shareholder return, compared with 6%, 26%, and 14% for the S&P 600, S&P 600 Automotive Parts & Equipment, and S&P 600 Industrials indices. Since its July 2023 spin-off through year-end, PHINIA has repurchased over 20% of outstanding shares.
The proxy emphasizes an independent, skills-based board (7 of 8 nominees independent), strong governance policies, and a pay-for-performance philosophy, with 86% of CEO and 66% of other NEO target compensation at risk and tied to company results.
Phinia Inc amendment to a Schedule 13G/A states that The Vanguard Group reports 0 shares beneficially owned of Phinia Inc common stock, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026 and cites SEC Release No. 34-39538 as the basis for disaggregated reporting by subsidiaries.
PHINIA INC. director Roger Wood reported a small grant of common stock tied to his existing equity awards. On the reported date, he acquired 16 shares of restricted stock at no cash price through automatic dividend reinvestment on previously granted restricted shares, as required by the award terms. Following this grant, he directly holds a total of 19,923 shares of PHINIA common stock, including 3,367 shares of restricted stock.
PHINIA INC. director Meggan M. Walsh received 16 shares of common stock as a grant, with no cash paid per share. These shares reflect automatic dividend reinvestment on her existing restricted stock awards. After this acquisition, she directly holds 7,560 common shares, including 3,367 restricted shares.
PHINIA INC. director Norman Daun reported an automatic grant of 16 shares of common stock in the form of restricted stock. These shares were acquired through the required reinvestment of dividends on his existing restricted stock awards, with no cash purchase involved.
Following this transaction, Daun directly holds 19,923 shares of PHINIA common stock, including 3,367 shares of restricted stock that remain subject to award terms. This filing reflects a routine, compensation-related adjustment to his equity position rather than an open-market trade.
PHINIA Inc. director Newton Latondra reported a small equity-based compensation update. On March 20, 2026, Latondra acquired 16 Deferred Restricted Stock Units (DRSUs), each economically equivalent to one share of PHINIA common stock. These units were acquired through automatic dividend reinvestment on outstanding DRSUs.
The DRSUs will vest on the one-year anniversary of the grant date and will settle into an equal number of PHINIA common shares upon Latondra’s termination of board service under the company’s Director Deferred Compensation Program and 2023 Stock Incentive Plan. Following this transaction, Latondra holds 3,367 DRSUs and 16,556 shares of common stock directly, indicating a routine, compensation-related adjustment rather than an open-market trade.
PHINIA INC. director Robin Kendrick received a grant of 22 Deferred Restricted Stock Units (DRSUs), each economically equivalent to one share of common stock. These DRSUs vest on the one-year anniversary of the grant date and will convert into common shares upon the end of board service under PHINIA’s Director Deferred Compensation Program and 2023 Stock Incentive Plan. The award resulted from automatic reinvestment of dividends on outstanding DRSUs. Following this grant, Kendrick holds 4,724 DRSUs, 16,556 shares of common stock directly, and 15,794 shares indirectly through a trust.
PHINIA INC. director Samuel R. Chapin reported an acquisition of 16 shares of common stock through an automatic dividend reinvestment on existing restricted stock awards. Following this grant-related acquisition, he holds a total of 23,923 common shares, including 3,367 shares of restricted stock.
Weerasinghe Rohan reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Rohan Weerasinghe received a grant of 41 deferred restricted stock units (DRSUs) on March 20, 2026. Each DRSU is economically equivalent to one share of common stock and will vest on the one-year anniversary of the grant date under the company’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.
After this grant, Weerasinghe holds 8,551 DRSUs and directly holds 22,686 shares of PHINIA common stock, with an additional 12 shares held indirectly through a managed account. The grant is a compensation-related award, not an open-market purchase.